Monday, Jul 20, 2020

Rearchitecting the Drug Launch Model

Manisha Shetty GulatiChief Growth Officer, Commure

HLTH Content Director, Jody Tropeano interviews Manisha Gulati, Chief Operating Officer, Clarify Health and Bhash Parasuraman, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer . They both recently presented on a HLTH GoLIVE series webinar called “Rearchitecting the drug launch model.” The discussion zeroed in on the incentives of regulators, payers, providers, and patients, which are often at odds with each other when it comes to drug launches.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved